Endovascular Reperfusion and Cooling in Cerebral Acute Ischemia (ReCCLAIM I)
Open Access
- 6 March 2013
- journal article
- research article
- Published by BMJ in Journal of NeuroInterventional Surgery
- Vol. 6 (2), 91-95
- https://doi.org/10.1136/neurintsurg-2013-010656
Abstract
Background The efficacy of hypothermia as a neuroprotectant has yet to be demonstrated in acute ischemic stroke. We conducted a phase I pilot study to assess the feasibility and safety of performing intravascular hypothermia after definitive intra-arterial reperfusion therapy (IAT). Methods ReCCLAIM (Reperfusion and Cooling in Cerebral Acute Ischemia) is a prospective single-arm open-label clinical trial conducted between May and August 2012 at Grady Memorial Hospital. Twenty patients with Alberta Stroke Program Early CT Score (ASPECTS) 5–7 and NIH Stroke Scale (NIHSS) score > 13 were enrolled and treated with intravascular cooling immediately after IAT. The incidence of pneumonia, deep vein thrombosis, cardiac arrhythmias and postoperative hemorrhages was documented for the entire length of stay. Secondary outcomes included blood–brain barrier (BBB) breakdown on gadolinium-enhanced MRIs and 90-day modified Rankin scores (mRS). Results The mean age, median NIHSS score and median final infarct volume were 59.7±14.6 years, 19 (IQR16–22) and 78 cm3 (IQR 16–107), respectively. The average time to the target temperature (33°C) was 64±50 min. Intracranial hemorrhages were found in three patients, of which one was symptomatic. Evidence of BBB breakdown was observed on 3 of 14 MRIs (21%). Six patients died due to withdrawal of care, whereas six patients (30%) achieved mRS of 0–2 at 90 days. In a binary logistical regression model comparing ReCCLAIM patients with 68 historical controls at our institution, hypothermia was protective against intracerebral hemorrhages (OR 0.09, 95% CI 0.02 to 0.56; pConclusions Hypothermia can be safely performed after definitive IAT in patients with large pretreatment core infarcts. A phase II study randomizing patients to hypothermia or normothermia is needed to properly assess the efficacy of hypothermia as a neuroprotectant for reperfusion injury. Trial registration number NCT01585597.Keywords
This publication has 20 references indexed in Scilit:
- Therapeutic Targets for Neuroprotection in Acute Ischemic Stroke: Lost in Translation?Antioxidants and Redox Signaling, 2011
- Intravenous Thrombolysis Plus Hypothermia for Acute Treatment of Ischemic Stroke (ICTuS-L)Stroke, 2010
- The Penumbra Pivotal Stroke TrialStroke, 2009
- Impact of Fever on Outcome in Patients With Stroke and Neurologic InjuryStroke, 2008
- Early Hemorrhagic Transformation of Brain Infarction: Rate, Predictive Factors, and Influence on Clinical OutcomeStroke, 2008
- A Critique of SAINT IIStroke, 2008
- Thrombolytic Toxicity: Blood Brain Barrier Disruption in Human Ischemic StrokeCerebrovascular Diseases, 2008
- Intracranial Hemorrhage Associated With Revascularization TherapiesStroke, 2007
- Safety and Efficacy of Mechanical Embolectomy in Acute Ischemic StrokeStroke, 2005
- Treatment of Comatose Survivors of Out-of-Hospital Cardiac Arrest with Induced HypothermiaThe New England Journal of Medicine, 2002